uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
prnewswire.com
CLBIO.STCLBIO.STSTO
Loading
Alerts
Want to monitor CLBIO.ST?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor CLBIO.STNews
Kyndryl Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KD
prnewswire.com
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
Driven Brands Holdings Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DRVN
prnewswire.com
Eos Energy Enterprises, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - EOSE
prnewswire.com
Plug Power Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PLUG
prnewswire.com
InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 20
accessnewswire.com
Hellman's mayonnaise maker Unilever in takeover talks with McCormick for food business
reuters.com
PLUG Investors Have Opportunity to Lead Plug Power Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
McCormick Issues Statement
prnewswire.com
Serbia secures US sanctions waiver for its NIS oil firm, energy minister says
reuters.com
Notice of Full Year Results and Investor Presentation
globenewswire.com
Morningstar Awards for Investing Excellence UK 2026: Winners Announced
businesswire.com
Apollo Global Management, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - APO
prnewswire.com
Prediction: This Will Be Amazon's Stock Price in 5 Years
fool.com
The Iran war is sending shockwaves through the world's busiest IPO market
cnbc.com
Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion
wsj.com
Transaction in Own Shares
globenewswire.com
The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ®
businesswire.com